Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes

NCT05473806 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic
Fibrosis, Liver
Diabetes Mellitus, Type 2

Interventions

DRUG: Pioglitazone 15 Mg Oral Tablet
DRUG: Evogliptin 5mg

Sponsor

Seung Up Kim